40 CFR § 721.5340 - Substituted benzothiazole-azo-substituted benzoquinoline nickel complex (generic).

§ 721.5340 Substituted benzothiazole-azo-substituted benzoquinoline nickel complex (generic).

(a) Chemical substance and significant new uses subject to reporting.

(1) The chemical substance identified generically as substituted benzothiazole-azo-substituted benzoquinoline nickel complex (PMN P-99–897) is subject to reporting under this section for the significant new use described in paragraph (a)(1) of this section.

(2) The significant new uses are:

(i) Release to water. Requirements as specified in § 721.90(a)(1), (b)(1), and (c)(1).

(ii) [Reserved]

(b) Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph.

(1) Recordkeeping. Recordkeeping requirements as specified in § 721.125(a), (b), (c), and (k) are applicable to manufacturers, importers, and processors of this chemical substance.

(2) Limitations or revocation of certain notification requirements. The provisions of § 721.185 apply to this section.

[68 FR 70178, Dec. 17, 2003]